The effect of lidocaine (n = 6) and procainamide (n = 12) on electrogram characteristics from electrically normal right ventricular and electrically abnormal left ventricular endocardial sites was determined in 18 patients with prior myocardial infarction. Bipolar electrograms were recorded during sinus rhythm with No. 6F catheters positioned at a left ventricular abnormal site (electrograms fulfilling two of the following criteria: amplitude <3 mV, duration >70 msec, or an amplitude to duration ratio < .046) and normal sites at the right ventricular apex (RVA) and right ventricular outflow tract (RVOT). All electrograms were recorded from the same location before and after intravenous lodicaine or procainamide administered to obtain mean serum concentrations of 4.2 ± 0.6 and 9.42 ± 2 Fg/ml respectively. Lidocaine and procainamide had no significant effect on sinus cycle length or electrogram amplitude. After lidocaine, no significant change in QRS width (112 ± 23 vs 114 + 24 msec), left ventricular electrogram duration (76 ± 21 vs 78 15 msec), or right ventricular electrogram duration (RVA 33 + 9 vs 33 + 10 msec, RVOT 31 9 vs 33 + 11 msec) was noted during sinus rhythm. At a paced cycle length of 600 msec, there was also no change in the paced QRS duration (197 vs 198 msec), the RVA electrogram duration (30 vs 32 msec), the RVOT electrogram duration (49 vs 52 msec), or the left ventricular electrogram duration (102 vs 108 msec). In contrast, after procainamide, QRS width prolonged from 110 + 31 to 127 + 33 msec (p < .001), and electrogram duration increased significantly (p < .001) at the left ventricular site (84 ± 17 to 101 ± 23 msec), the RVA (32 ± 11 to 38 ± 13 msec), and the RVOT (37 + 12 to 44 ± 15 msec). Similarly, at a pacing cycle length of 600 msec, QRS duration increased from 194 to 226 msec (p < .001), RVA electrogram duration increased from 32 to 36 msec (p < .05), RVOT electrogram duration increased from 34 to 39 msec, and left ventricular electrogram duration increased from 86 to 108 msec. The observations that lidocaine had no effect on local electrogram duration and procainamide prolonged indexes of conduction in both normal and chronically infarcted myocardium to the same degree are consistent with, but do not establish with certainty, the hypothesis that the ionic basis for impulse propagation is similar in normal and infarcted tissue.
electrically abnormal endocardial regions have not been previously described. Although the effect of lidocaine' and procainamide2`4 on indexes of conduction and refractoriness in the atrium, the atrioventricular node, the His-Purkinje system, and ventricular muscle have been documented, it is not known whether lidocaine and procainamide exert different effects on normal and abnormal endocardial electrograms. In addition, along with other studies it may help provide a clue to the mechanism for the efficacy of antiarrhythmic agents in the management of ventricular tachyarrhythmias associated with chronic coronary artery disease and may help to further define the electrophysiologic characteristics of myocardial cells that survive in infarcted areas. Thus, the purpose of our study was to determine the effect of lidocaine and procainamide on electrogram characteristics at normal and chronically infarcted sites.
Methods
Patient population. Eighteen patients referred to the Hospital of the University of Pennsylvania for electrophysiologic evaluation of sustained ventricular tachyarrhythmias underwent endocardial catheter mapping during sinus rhythm. All patients had coronary heart disease documented by coronary angiography, with previous myocardial infarction at least 6 months before study, In six patients the effects of lidocaine and in 12 patients the effects of procainamide on electrogram characteristics were determined. There was no difference in clinical characteristics of the groups (tables 1 and 2).
Electrophysiologic study. All studies were performed in patients in the nonsedated, postabsorptive state after informed written consent had been obtained. Before endocardial mapping was peformed, all antiarrhythmic agents were discontinued for at least five half-lives, and no patient had taken amiodarone. A (No. 6F USCI) quadripolar catheter was inserted percutaneously into the femoral artery and advanced to the left ventricle under fluoroscopic guidance. Two quadripolar catheters were also inserted percutaneously into the femoral vein and advanced to the right ventricular apex and outflow tract. The catheters had a 5 mm interelectrode distance with a width of the electrode ring of 2 mm. The schema used for endocardial left ventricular mapping is shown in figure 1. All the electrograms were bipolar and were filtered at 30 to 500 Hz. Electrograms from the left ventricle were recorded with a 10 mm interelectrode distance at variable and fixed gains (1 cm = 1 mV). The 10 mm interelectrode distance was used for comparison with previously performed studies of mapping in sinus rhythm. Intracardiac electrograms from the right ventricular apex and outflow tract were recorded with a 5 mm interelectrode distance at a variable gain; for each recording a 1 mV calibration signal was obtained. We routinely use a 5 mm interelectrode distance for recording right ventricular electrograms. In two patients right ventricular electrograms before and after procainamide were recorded at a 5 and 10 mm interelectrode distance at variable and fixed gains to exclude differences in electrogram durations due to the recording technique.
Activation times in bipolar filtered electrograms are generally taken as the time the first rapid deflection crosses the isoelectric line. Intracardiac recordings and surface leads 1, aVF, and V1 were simultaneously displayed on a multichannel oscilloscope right bundle branch (Electronics for Medicine VR16) and stored on analog magnetic tape (Honeywell 5600) and recorded on a 16-channel Mingograf (Siemens-Elema) at a paper speed of 250 mm/sec. All left ventricular electrograms were recorded from abnormal sites. Abnormal sites were defined by criteria from sinus rhythm endocardial catheter mapping,4 fulfilling two of the following criteria: an amplitude of 3 mV or less, a duration of 70 msec or more, or an amplitude-to-duration ratio of 0.046 or less. All right ventricular sites were normal as defined by these criteria. Electrogram amplitude and duration were manually digitized with a Hewlett-Packard 9816 computer and digitizing system. Measurement reproducibility was within 2 msec of electrogram duration and 10% of electrogram amplitude as measured by two observers. The amplitude (in mV) was defined as the maximal upward to maximum downward reflection measured by the variable-gain bipolar electrograms. The duration (in msec) was defined by the onset of the earliest electrical activity to the point of the final crossing of the baseline of the local electrical activity. The duration of the low-amplitude activity of the abnormal left ventricular sites was measured from the fixed gain, as described previously. 5 The maximum duration of the QRS complex was measured from lead I, aVF, or V1. Electrograms were recorded during sinus rhythm and after 15 beats of pacing at a cycle length of 600 msec. In three patients with a sinus tachycardia pacing was performed at a cycle length of 500 msec. We analyzed the fifteenth beat because we found, as has been previously reported, that a close to steady-state drug effect was reached by this point. Activation times in sinus rhythm were believed to represent a combination of the rapidity of His-Purkinje and muscle-to-muscle activation, whereas those during ventricular pacing were believed to represent predominantly muscle-to-muscle impulse spread. Local electrogram duration provided an index of localized myocardial activation. However, activation times in bipolar filtered electrograms are generally taken as the time the first rapid deflection crosses the isoelectric line. In examining activation of the left ventricular site, electrogram onset rather than activation time was evaluated because a discrete activation time was difficult to reproducibly identify in these fractionated electrograms.
Lidocaine infusion. In six patients with the catheters in the same location lidocaine (3 mg/kg over 15 min) was administered intravenously followed by maintenance infusion of 3 mg/min. Procainamide infusion. In 12 patients procainamide (15 CONTROL 1 mg/kg at 50 mg/min) was infused intravenously and was followed by maintenance infusion of 0.11 mg/kg/min. Before repeating electrogram recordings after lidocaine or procainamide infusion, catheter position was confirmed by multiplane fluoroscopy. Electrograms were recorded beginning at least 5 min after the maintenance infusion was started. Lidocaine and procainamide serum concentrations were obtained immediately after the registration of the electrograms. Less than 1 min was required to acquire the data in sinus rhythm and during pacing. Lidocaine and procainamide serum levels were determined by an enzyme-multiplied immunoassay technique. Data analysis. Four to five complexes in sinus rhythm were assessed before and after lidocaine or procainamide. Results are expressed in milliseconds or millivolts and percentage change. Student's t test for paired data was used to compare electrocardiographic characteristics before and after lidocaine and procainamide administration and two-way analysis of variance was applied for comparing percentage changes in the left and right ventricular sites after procainamide. Results are expressed as the mean + SD unless otherwise indicated.
Results
Effects of lidocaine (figure 2 102±30 108±30 C = control; L = lidocaine; RVA = right ventricular apex; RVOT = right ventricular outflow tract: LV = left ventricle; NSR = normal sinus rhythm; 600 = pacing at a cycle length of 600 msec from the RVA. 28 15) or the onset of the left ventricular electrogram (31 45 vs 32 ± 43). In addition, the right and left ventricular electrogram amplitudes during sinus rhythm were not significantly altered. The number and morphology of individual components of the abnormal left ventricular electrograms were unchanged after lidocaine. During pacing at a cycle length of 600 msec from the right ventricular apex, lidocaine did not significantly delay intraor interventricular conduction time. During pacing from the right ventricular apex mean right ventricular outflow tract activation time was 73 ± 11 at control and 74 ± 16 after lidocaine. Similarly, the onset of the left ventricular electrogram occurred at 73 ± 37 msec at control and 73 ± 36 msec after lidocaine was given. As was true during sinus rhythm, QRS electrogram duration and amplitude were unchanged by lidocaine during right ventricular apex pacing (tables 3 and 4). Electrogram duration at the right ventricular outflow tract was longer than that at the right ventricular apex both during sinus rhythm and pacing before and after lidocaine.
Effects of procainamide ( figure 3 ). Procainamide (mean serum concentration, 9.4 pug/ml, range 6.7 to 14.2 ,ug/ml) did not alter the mean sinus cycle length (675 ± 78 vs 680 ± 110 msec). The mean QRS duration prolongedfrom 110 ± 31 to 127 ± 33msec(+16%). The mean duration of the left ventricular electrograms increased from 84 ± 17 to 101 ± 23 msec ( + 20%). Corresponding values for the right ventricular apex and outflow tract after procainamide were 32 ± 11 vs 38 13 msec (+ 19%) and 37 12 vs 44 15 msec (+ 19%), respectively (table 5) . Thus, the percentage change in electrogram duration was the same at the normal right ventricular and abnormal left ventricular sites (p = NS by two-way ANOVA). After the infusion of procainamide right ventricular activation times were significantly delayed in sinus rhythm; mean right ventricular apex activation increased from 30 + 13 to 36 14 msec and mean right ventricular outflow tract activation increased from 34 + 20 to 41 22 msec. However, procainamide did not affect the mean onset of left ventricular activation (15 + 25 to 16 31 msec). During pacing at a cycle length of 600 msec from the right ventricular apex, procainamide delayed right and left ventricular activation and prolonged electrogram duration ( The morphology of the intracardiac electrograms was unchanged after procainamide, and no loss of components of the abnormal left ventricular electrograms or new components were noted. Electrogram amplitudes in electrically abnormal and normal areas were not significantly changed by either drug (table 4) .
Therapy with procainamide. Five of the 12 patients who received intravenous procainamide had been previously treated with oral procainamide. Two of these had the drug discontinued because of side effects but received procainamide in the electrophysiology laboratory to predict the response to the type la agents.2 Two patients had had clinical recurrences on procainamide and one had been treated effectively for approximately 1 year. No patient was treated with lidocaine. The patients with clinical recurrences had electrogram changes similar to those in patients who had not been 1034 treated with the drug and to those in the patient who was apparently effectively treated, but the numbers were too small to allow statistical analysis.
Discussion
In this study the effects of lidocaine and procainamide on the duration and amplitude of intracardiac electrograms in electrically normal right ventricular sites and electrically abnormal left ventricular sites were compared. Similar results were obtained when examining activation times, a measure of His-Purkinje and interventricular conduction, and electrogram duration, an index of local conduction. Lidocaine had no effect on any of the measured variables, even in abnor- Ccontrol; P = procainamide: RVA = right ventricular apex; RVOTright ventricular outflow tract: LV = left ventricle: NSR = normal sinus rhythm.
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1 . A It mal left ventricular sites, whereas procainamide produced a 13% to 27% increase. The degree of conduction slowing produced by a drug at slow stimulation frequencies may help determine its ability to prevent or potentiate initiation of the tachycardia.
Studies in human tissue removed at cardiac surgery have demonstrated some populations of cells with abnormal action potentials and subthreshold potentials.6' 7 However, an effect of preparation of the tissue on action potentials could not be excluded in either report. In contrast, several investigators9-13 have demonstrated a progressive normalization of action potential characteristics after experimental myocardial infarction and postulated that fractionated electrograms result from ingrowth of fibrosis superimposed on normal surviving muscle bundles.
The effects of a series of different pharmacologic agents with effects on different ionic channels and at different voltages on conduction times and electrogram durations could potentially help elucidate action potential characteristics in such regions. A limitation of any extracellular recording technique is that the observed activity represents a net sum of that produced by a group of cells. Thus, it is possible that small numbers of viable cells are present within the recording area that are not manifest in the extracellular electrogram. We believe this is unlikely for two reasons. The abnormal left ventricular electrograms we studied were of prolonged duration and very low amplitude with occasional isoelectric periods and thus cancellation of forces and the potential for obscuring certain signals was minimized. In addition, studies in vitro have suggested that even relatively small groups of cells may produce discernible components in extracellular electrograms.1' Even if small numbers of cells that are not reflected in the extracellular electrogram are present, our data demonstrate drug effects on the larger number of cells producing abnormal electrograms.
Our observation that lidocaine had no significant effects on local electrogram characteristics at chronically infarcted left ventricular sites is consistent with normal fast action potentials since lidocaine has a high affinity for partially depolarized tissue because it selectively decreases partially inactivated Na+ current in hypoxic or ischemic cells.13 ' 14 This has been confirmed by many experimental studies15-17 in which lidocaine caused slowing of conduction in the ischemic zone after myocardial infarction but had no effect on conduction in the adjacent normal zone. Hondeghem18 reported that neither lidocaine nor quinidine had major effects on electrograms in acutely ischemic canine myo-cardium. However, as noted above, the electrophysiology of acute ischemia may be vastly different from that in chronic infarction. Our finding that lidocaine did not effect the electrogram duration recorded from chronically infarcted tissue is in contrast to a study by Wiener et al.,19 who found significant intraventricular conduction delay in the distribution of the left anterior descending artery after administration of lidocaine in patients with prior anterior myocardial infarction who underwent bypass surgery. However, possible effects of surgery on these results cannot be excluded.
The observation that procainamide changed conduction characteristics of intracardiac electrograms during sinus rhythm in noninfarcted and chronically infarcted areas to the same degree is also compatible with normal action potential characteristics in chronically infarcted sites. Prolongations of electrogram duration after procainamide could be due to conduction slowing secondary to depression of the sodium channel or to changes in cell-to-cell coupling. As with lidocaine, the depressant effect of procainamide on the inward sodium current2 3 may vary depending on the resting membrane potential and the presence of ischemia or hypoxia.20' 21 For example, Hondeghem et al.21 have shown that hypoxic guinea pig papillary muscle is far more sensitive to physiologic concentrations of procainamide than oxygenated cells. The effects of procainamide on cell-to-cell coupling and passive membrane properties in infarcted tissue are far less clear. Either conduction slowing due to worsened cell-to-cell coupling or improved cell-to-cell coupling with activation of previously inexcitable areas could potentially explain a prolongation of electrogram duration after procainamide. Based on experimental findings, procainamide has relatively small effects on passive membrane properties in normal cardiac tissue.22'23 In a recent study Kadish et al. 24 demonstrated that procainamide has nonhomogenous effects on conduction in anisotropic ventricular muscle: conduction velocity of fiber orientation was depressed by a greater extent in the longitudinal axis than transverse to it. They attributed these findings to possible differences in drug binding depending on propagation direction and/or to changes in junctional resistivity. Since the effects of procainamide on passive membrane properties in normal uniform anisotropic cardiac tissue are small and procainamide had similar effects on local electrogram duration in normal and chronically infarcted regions, one can assume that effects of procainamide on passive membrane properties in nonuniform anisotropic tissue are minimal during sinus rhythm. Vol. 77, No. 5, May 1988 Effects of lidocaine and procainamide on slowchannel current or possible abnormal slow responses in chronically infarcted tissue are not well defined. However, it is known that lidocaine does not exert its antiarrhythmic action by depressing slow-channel 25 -hne current. The effects of procainamide on slow-channel activity have not been well worked out, but an article by Hordof et al.26 suggests that procainamide may effect slow-channel conduction as well. However, these effects were small and were seen mainly at a concentration of 40 mg/liter.
In conclusion, since the effects of lidocaine and procainamide on electrogram duration in normal and infarcted endocardial tissue were similar, the hypothesis that membrane action potentials of surviving endocardial cells in chronically infarcted areas are similar to those in normal cardiac tissue is supported. Since procainamide prolonged electrogram duration in normal and chronically infarcted regions to a similar degree and lidocaine had no effect on electrogram duration, we believe that surviving endocardial cells in chronic myocardial infarction have normal resting membrane potentials. If they were associated with markedly depressed action potentials, lidocaine would have also prolonged electrogram duration. However, the similar effects of lidocaine and procainamide on electrograms from normal and abnormal areas do not absolutely establish that action potentials in chronically infarcted tissue are normal. For example, cells with mildly depressed resting membrane potentials might not be affected by lidocaine. Thus, further work will be required to verify the hypothesis developed from transmembrane potential recordings in animal preparations of infarction that action potential in surviving endocardial tissue in human infarctions is. in fact,
normal.
Limitations. Criteria for normal electrograms in sinus rhythm mapping of right ventricular sites are not established. The criteria we used have been established for the left ventricle for classifying right ventricular sites as normal.
Since our primary objectives were to evaluate the effects in sinus rhythm and to use the effects of procainamide and lidocaine to help identify the basis for conduction in chronic infarction, we did not examine drug effects at rapid stimulation frequencies. At such short pacing cycle lengths both drugs might be expected to have similar effects, regardless of cellular electrophysiologic characteristics in such regions. In addition, we examined fractionated left ventricular electrograms, which were not necessarily at the site of origin of ventricular tachycardia. However, we have previously shown that while such electrograms may be present at sites of tachycardia origin, similar electrograms may be found in other regions. 27 
